India's pharmaceutical exports crossed $28 billion till February FY26, growing over 5% despite global challenges. Growth was driven by formulations, vaccines, and biologicals. The US and Europe remain key markets. Officials highlight strong global demand and quality standards, while government initiatives continue to support expansion and boost the sector's long-term growth.